Breakthrough in Cancer Gene Therapy: Researchers Develop New Anticancer Dendrimers

Scientists at Instituto Superior Tecnico have made significant strides in cancer gene therapy by developing novel dendrimers that demonstrate intrinsic anticancer activity. According to the research, these dendrimers, specifically PUREG4-OEI48 and PUREG4-OCEI24, disrupt cell membrane integrity, interact with mitochondria, and induce cell death by promoting apoptosis. The findings indicate that these dendrimers may be effective in targeting cancer cells and inhibiting disease progression.

Key Takeaways:

• Researchers have designed two polycationic core-shell PURE biodendrimers, PUREG4-OEI48 and PUREG4-OCEI24, which exhibit intrinsic anticancer activity.
• These dendrimers target the mitochondrial membrane, activating distinct cell death mechanisms, and demonstrate cytotoxic effects on cancer cells.
• PUREG4-OEI48 disrupts cell membrane integrity, interacts with mitochondria, and induces cell death by promoting apoptosis.
• PUREG4-OCEI24, which is more hydrophobic and less cationic than PUREG4-OEI48, exhibits cytotoxic effects on cancer cells and inhibits wound healing after 24 hours.
• The mechanism of action of the dendrimers may be partially associated with cell necrosis.
• The study has been peer-reviewed, and the findings suggest that these dendrimers may be effective in targeting cancer cells and inhibiting disease progression.
• The researchers have designed these dendrimers as synthetic mimics of anticancer peptides (SMACPs) to improve their anticancer efficacy.
• The study highlights the potential of nanoparticles, particularly dendrimers, in cancer treatment, diagnosis, and disease monitoring.

Statistics:

• 51% of cancer-related deaths worldwide are caused by cancer, with only a small fraction of the drug reaching the tumour site.
• 20% or more of cancer patients develop resistance to chemotherapy, and current treatments often pose major drawbacks, including high toxicity and poor distribution.
• The researchers found that PUREG4-OEI48 and PUREG4-OCEI24 exhibit cytotoxic effects on cancer cells at an IC concentration of 20 μM.
• The study took 24 hours to evaluate the cytotoxic effects of PUREG4-OCEI24 on cancer cells.

Sources:

• Designing anticancer polyurea biodendrimers: the role of core-shell charge/hydrophobicity modulation. Biomaterials Science, 2025.
• Instituto Superior Tecnico. iBB-Institute for Bioengineering and Biosciences and Associate Laboratory i4HB-Institute for Health and Bioeconomy.
• Royal Society of Chemistry - www.rsc.org/;
• Biomaterials Science - pubs.rsc.org/en/journals/journalissues/bm